The great German choreographer's landmark work, which was first presented in 1978 in Wuppertal, is revived on the main stage ...

A money manager at Carl Icahn’s investment firm is suing Bausch + Lomb Corp. and his billionaire employer, alleging he was ...

Strong operating results did not stop one fund from walking away entirely, raising questions about how much patience volatile ...

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 2.2% in the morning session after Citigroup upgraded its rating on ...

Bausch + Lomb's stock remains a "Hold" despite the latest financial results. Here's what investors need to keep in mind.

Bausch + Lomb Corporation ( ($BLCO) ) has issued an update. On December 17, 2025, Bausch + Lomb Corporation announced the appointment of Eduardo ...

Bausch + Lomb, a company that started as a small optical goods shop in upstate New York and grew to become a global ophthalmic products business, is returning to the public markets. The company has ...

Pina Bausch's ‘Sweet Mambo' will come to Sadler's Wells Theatre from Wednesday 11 February – Saturday 21 February 2026. ...

Shares of Bausch Health Company (NYSE: BHC) were jumping 4.4% at 10:54 a.m. ET on Wednesday after rising as much as 11.8% earlier in the day. The gain came after the company announced results so far ...

Bausch + Lomb refinances $2.8B in loans, lowering interest rates and extending maturity to 2031. Learn how this move impacts BLCO’s financial outlook.

On Saturday night, at the Brooklyn Academy of Music, New York saw the last performance of the last work by Pina Bausch, “…como el musguito en la piedra, ay si, si, si …” (“like moss on a stone ”). The ...